ArticleAmerican journal of translational research2023
Effect of hemodialysis combined with calcitriol on cardiac function and BNP in patients with hyperparathyroidism secondary to nephropathy.
Article in American journal of translational research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo explore the effect of hemodialysis plus calcitriol on cardiac function and BNP in patients with hyperparathyroidism secondary to nephropathy.
methodsIn this retrospective study, a total of 80 patients with nephropathy secondary to hyperparathyroidism treated in our hemodialysis center from January 2018 to January 2020 were included. The patients were divided into a combination group (n=50) and a control group (n=30) according to treatment plan. Both groups were treated with hemodialysis, and the combination group was treated with additional calcitriol. The heart rate, heart functions such as left ventricular end-systolic volume (LVESV), left ventricular ejection fraction (LVEE), left ventricular end-diastolic diameter (LVEDD), left ventricular end-systolic diameter (LVESD), brain natriuretic peptide (BNP) level, blood calcium and phosphorus level, intact parathyroid hormone (iPTH) and alkaline phosphatase (ALP) level, total effective rate, and adverse reaction rate of the two groups were compared.
resultsCompared to the control group, the heart rate, LVEE, LVEDD and LVESD, BNP level, blood calcium and phosphorus level, and the incidence of adverse reactions of the combination group were lower, while LVESV level, iPTH, and ALP levels, and the total effective rate were higher.
conclusionHemodialysis combined with calcitriol can better improve cardiac function and BNP level of patients than hemodialysis alone.
Indexed as
Identifiers
37193143PMC10182481W4376872263What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.